Healthtech Late Stage Investors & VC Firms
847 firms in this list, with a median first check of $1M. 197 of them lead rounds. Generated from verified public data and updated continuously.
20/20 HealthCare Partners LLC
AuburndaleSeed–Late Stage
7 people
Invest Tech
São PauloPre-Seed–Late Stage
4 people
Tana Africa Capital
JohannesburgGrowth–Late Stage
10 people
Avego BioScience Capital
AlpharettaSeries A–Late Stage
Clearspring Capital Partners
TorontoGrowth–Late Stage
12 people
EquityPitcher Ventures
ZürichSeed–Late Stage
12 people
Ming capital
ShenzhenSeed–Late Stage
6 people
Oquirrh Ventures
Salt Lake CityGrowth–Late Stage$10M – $50M
6 people
Avestria Ventures
San FranciscoPre-Seed–Late Stage
4 people
CapMan
HelsinkiSeries A–Late Stage$2.2M – $64.8M
4 people
Altered Capital
AucklandSeries A–Late Stage
12 people
Blume Ventures
MumbaiSeed–Late Stage$650K – $36M
12 people
Marathon Venture Partners
Pre-Seed–Late Stage
Rock Springs Capital
BaltimoreLate Stage
12 people
Vesalius Biocapital III Partners SàRL
ConternSeed–Late Stage$10.8M
12 people
Hakluyt Capital
LondonSeries B–Late Stage
8 people
IDG Capital
Hong KongPre-Seed–Late Stage$3M – $200M
5 people
Livingbridge
LondonGrowth–Late Stage
8 people
Oxford Investment Consultants LLP
OxfordSeed–Late Stage
11 people
Utiliti Group
SydneySeed–Late Stage
Reaction
Seed–Late Stage
11 people
Pandect Bioventures
WoodsideSeed–Late Stage
10 people
OSK Ventures International
Kuala LumpurSeed–Late Stage$1.3M – $6.1M
CSC Upshot
Palo AltoPre-Seed–Late Stage$100K – $1.5M
5 people
Related lists
Healthtech Investors & VC Firms (3208)Late Stage Investors & VC Firms (2864)Healthtech Seed Investors & VC Firms (2488)Healthtech Series A Investors & VC Firms (2210)Healthtech Investors & VC Firms in United States (1616)Healthtech Pre-Seed Investors & VC Firms (1328)Healthtech Series B Investors & VC Firms (1216)Healthtech Growth Investors & VC Firms (1213)Late Stage Investors & VC Firms in United States (1101)Late Stage Investors & VC Firms in Global (857)
Data sourced from public filings and firms' own websites — see our methodology.




















































